Want to see IN:NATHBIOGEN full AI Analyst Report?

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Price & Analysis

3 Followers

NATHBIOGEN Stock Chart & Stats

₹152.80

-₹1.00(-0.61%)

At close: Jul 28 4:00 PM EDT

₹152.80

-₹1.00(-0.61%)

Day’s Range― - ―

52-Week Range₹126.75 - ₹207.00

Previous CloseN/A

Volume7.72K

Average Volume (3M)1.11K

Market Cap

₹2.66B

Enterprise Value₹3.05K

Total Cash (Recent Filing)₹759.95M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)7.5

Beta1.14

Next Earnings

Oct 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.43%

Share Statistics

EPS (TTM)18.43

Shares Outstanding19,004,000

10 Day Avg. Volume1,316

30 Day Avg. Volume1,108

Financial Highlights & Ratios

PEG Ratio1.86

Price to Book (P/B)0.38

Price to Sales (P/S)0.58

P/FCF Ratio-10.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthReported revenue growth of about 21% supports the company’s ability to expand sales across its agricultural seed portfolio. Sustained top-line growth can improve operating scale, strengthen distributor reach, and provide a foundation for reinvestment in breeding, production, and marketing over the next several quarters.

Conservative LeverageLow debt relative to equity provides financial resilience and reduces the burden of interest and refinancing obligations. This conservative capital structure preserves flexibility to fund seed development, production capacity, and distribution needs while offering greater protection if agricultural conditions weaken.

Positive ProfitabilityPositive net income, a roughly 9% net margin, and an approximately 11% operating margin show that the core seed business remains profitable. Continued operating profitability can support internal funding, reinforce the company’s ability to serve distributors, and provide a base for longer-term earnings development.

Bears Say

Weak Cash ConversionNegative operating and free cash flow despite positive earnings indicates that reported profitability is not currently converting reliably into cash. This can reduce near-term funding flexibility and may constrain the company’s ability to finance inventory, seasonal sales requirements, or ongoing investment without relying more heavily on balance-sheet resources.

Margin CompressionThe substantial decline in net margin shows that earnings quality and profitability have weakened even as the company remains profitable. Persistent margin pressure would reduce the benefit of revenue growth, limit internal cash generation, and make future results more sensitive to changes in product mix and operating costs.

Earnings VolatilityNegative reported EPS growth and the history of a sharp loss point to uneven earnings performance rather than a consistently compounding profit profile. Such volatility can make business planning and capital allocation more difficult, while reducing confidence that current profitability will translate into steadily improving shareholder returns.

Nath Bio-Genes (India) Ltd. News

Nath Bio-Genes Releases Investor Presentation on Unaudited Q3 and 9MFY26 Results

Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) has issued an announcement. Nath Bio-Genes (India) Ltd. has released an...

8M ago

Nath Bio-Genes Shuts Trading Window Ahead of Q3 FY26 Results

Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) has provided an update. Nath Bio-Genes (India) Ltd. has announced that...

9M ago

Nath Bio-Genes Ensures Regulatory Compliance with SEBI Regulations

An update from Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) is now available. Nath Bio-Genes (India) Ltd. has...

12M ago

Nath Bio-Genes Releases Q3 FY25 Financial Results

An update from Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) is now available. Nath Bio-Genes (India) Limited has...

2y ago

NATHBIOGEN FAQ

What was Nath Bio-Genes (India) Ltd.’s price range in the past 12 months?

Nath Bio-Genes (India) Ltd. lowest stock price was ₹126.75 and its highest was ₹207.00 in the past 12 months.

What is Nath Bio-Genes (India) Ltd.’s market cap?

Nath Bio-Genes (India) Ltd.’s market cap is ₹2.66B.

When is Nath Bio-Genes (India) Ltd.’s upcoming earnings report date?

Nath Bio-Genes (India) Ltd.’s upcoming earnings report date is Oct 21, 2026 which is in 17 days.

How were Nath Bio-Genes (India) Ltd.’s earnings last quarter?

Nath Bio-Genes (India) Ltd. released its earnings results on Jul 29, 2026. The company reported ₹16.976 earnings per share for the quarter.

Is Nath Bio-Genes (India) Ltd. overvalued?

According to Wall Street analysts Nath Bio-Genes (India) Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nath Bio-Genes (India) Ltd. pay dividends?

Nath Bio-Genes (India) Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 1.43%. See more information on Nath Bio-Genes (India) Ltd. dividends here

What is Nath Bio-Genes (India) Ltd.’s EPS estimate?

Nath Bio-Genes (India) Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nath Bio-Genes (India) Ltd. have?

Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding.

What happened to Nath Bio-Genes (India) Ltd.’s price movement after its last earnings report?

Nath Bio-Genes (India) Ltd. reported an EPS of ₹16.976 in its last earnings report. Following the earnings report the stock price went down -1.467%.

Which hedge fund is a major shareholder of Nath Bio-Genes (India) Ltd.?

Currently, no hedge funds are holding shares in IN:NATHBIOGEN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Nath Bio-Genes (India) Ltd.

Nath Bio-Genes (India) Limited is dedicated to the development, preparation, and worldwide distribution of both hybrid and genetically modified (GM) seeds, catering to demand within India and internationally. Its business operations are organized into two main divisions: agricultural pursuits and trading endeavors. The company provides a wide array of seeds, including: Cereals: Maize, paddy, millet, wheat, and jowar. Fruits: Various fruit seed varieties. Fiber and Oil-Producing Crops: Notably cotton and mustard. Vegetables: A comprehensive selection such as chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. Additionally, Nath Bio-Genes supplies agricultural enhancement products, offering crop protection supplements like the WINPro GOLii, WINall, and Win Chi Win growth enhancers. It also provides forage supplements, NUTRIMAX GOLD and NUTRIMAX, specifically formulated to boost fodder production. The company disseminates its products via an extensive network that includes distributors, dealers, and its own processing facilities. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.